What is the name of efforts to reduce the potential harms to older adults posed by polypharmacy?

Kaufman DW, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337–44.
PubMed Article Google Scholar
Lombardi TP, Kennicutt JD. Promotion of a safe medication environment: focus on the elderly and residents of long-term care facilities. Medsc Pharm. 2001;2(1):23–8.
Google Scholar
Thomsen LA, et al. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother. 2007;41(9):1411–26.
PubMed Article Google Scholar
Topinkova E. Aging, disability and frailty. Ann Nutr Metab. 2008;52(Suppl. 1):6–11.
CAS PubMed Google Scholar
Gill TM, Robison JT, Tinetti ME. Predictors of recovery in activities of daily living among disabled older persons living in the community. J Gen Intern Med. 1997;12(12):757–62.
CAS PubMed PubMed Central Article Google Scholar
Alagiakrishnan K, Wiens C. An approach to drug induced delirium in the elderly. Postgrad Med J. 2004;80(945):388–93.
CAS PubMed PubMed Central Article Google Scholar
Larson EB, et al. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987;107(2):169–73.
CAS PubMed Article Google Scholar
Moore AR, O’Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging. 1999;15(1):15–28.
CAS PubMed Article Google Scholar
Huffman GB. Evaluating and treating unintentional weight loss in the elderly. Am Fam Physician. 2002;65(4):640–50.
PubMed Google Scholar
Jyrkka J, et al. Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiol Drug Saf. 2011;20(5):514–22.
PubMed Article Google Scholar
Gnjidic D, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–95.
PubMed Article Google Scholar
Lai SW, et al. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore). 2010;89(5):295–9.
PubMed Article Google Scholar
Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc. 1999;47(1):40–50.
CAS PubMed Article Google Scholar
Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30–9.
CAS PubMed Article Google Scholar
Thapa PB, et al. Antidepressants and the risk of falls among nursing home residents. N Engl J Med. 1998;339(13):875–82.
CAS PubMed Article Google Scholar
Talasz H, Lechleitner M. Polypharmacy and incontinence. Z Gerontol Geriatr. 2012;45(6):464–7.
CAS PubMed Article Google Scholar
Akazawa M, et al. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010;8(2):146–60.
PubMed Article Google Scholar
Lopez-Sendon JL, Mena MA, de Yebenes JG. Drug-induced parkinsonism in the elderly: incidence, management and prevention. Drugs Aging. 2012;29(2):105–18.
CAS PubMed Article Google Scholar
Onder G, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962–8.
PubMed Article Google Scholar
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001;41(2):192–9.
CAS Article Google Scholar
Bates DW, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Events Prevention Study Group. JAMA. 1997;277(4):307–11.
CAS PubMed Article Google Scholar
Fick DM, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.
PubMed Article Google Scholar
Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155(18):1949–56.
CAS PubMed Article Google Scholar
Perry DP. When medicine hurts instead of helps. Consult Pharm. 1999;14:1326–30.
Google Scholar
Gurwitz JH, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109(2):87–94.
CAS PubMed Article Google Scholar
Han BH, et al. Effect of statin treatment vs usual care on primary cardiovascular prevention among older adults: the ALLHAT-LLT randomized clinical trial. JAMA Intern Med. 2017;177(7):955–65.
PubMed PubMed Central Article Google Scholar
Jyrkka J, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493–503.
PubMed Article Google Scholar
Steinman MA, Hanlon JT. Managing medications in clinically complex elders: “There’s got to be a happy medium”. JAMA. 2010;304(14):1592–601.
CAS PubMed PubMed Central Article Google Scholar
Fu AZ, et al. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care. 2007;45(5):472–6.
PubMed Article Google Scholar
Hug BL, et al. The costs of adverse drug events in community hospitals. Jt Comm J Qual Patient Saf. 2012;38(3):120–6.
PubMed Google Scholar
Rochon PA, TJ, Gill SS, Gurwitz JH. In: Halter JB, Tinetti ME, Studenski S, High KP, Asthana S, editors. Hazzard’s Geriatric Medicine and Gerontology. New York (NY): McGraw-Hill; 2009. p. 289–302.
Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997;157(18):2089–96.
CAS PubMed Article Google Scholar
Hoonhout LH, et al. Direct medical costs of adverse events in Dutch hospitals. BMC Health Serv Res. 2009;9:27.
PubMed PubMed Central Article Google Scholar
Rottenkolber D, Hasford J, Stausberg J. Costs of adverse drug events in German hospitals: a microcosting study. Value Health. 2012;15(6):868–75.
PubMed Article Google Scholar
Santibanez-Beltran S, et al. Economic cost of polypharmacy in the elderly in primary health care. Rev Med Inst Mex Seguro Soc. 2013;51(2):192–9 (in Spanish).
PubMed Google Scholar
Mangin D, Heath I, Jamoulle M. Beyond diagnosis: rising to the multimorbidity challenge. BMJ. 2012;44:e3526.
Article Google Scholar
de Ruijter W, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;338:a3083.
PubMed PubMed Central Article Google Scholar
Golomb BA, Bui AK. Fasting glucose positively predicts word memory performance in older men. Circulation. 2014;130(Suppl. 2):A13365.
Google Scholar
BA, G. The starving cell: metabolic syndrome as an adaptive process. Available from: Nature Precedings; 2011.
The Action to Control Cardiovascular Risk in Diabetes. Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.
Article Google Scholar
Tinetti ME, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174(4):588–95.
PubMed PubMed Central Article Google Scholar
Lipska KJ, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174(7):1116–24.
PubMed PubMed Central Article Google Scholar
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200–5.
CAS Article PubMed Google Scholar
Makary MA, Daniel M. Medical error: the third leading cause of death in the US. BMJ. 2016;353:i2139.
PubMed Article Google Scholar
Garfinkel D. Geriatric boom catastrophe: a major medical, economic and social nightmare of the 21st century. Proceedings of the 16th Congress of the International Association of Gerontology 1997; 364.
Boyle P. Global burden of cancer. Lancet. 1997;349(Suppl. 2):23–6.
Article Google Scholar
Ershler WB. Geriatrics and medical oncology: finding the common ground. J Gerontol A Biol Sci Med Sci. 1997;52(6):M327–8.
CAS PubMed Google Scholar
Garfinkel D. The tsunami in 21st century healthcare: the age-related vicious circle of co-morbidity. J Nutr Health Aging. 2013;17(Suppl. 1):SS24, 227–C1, S96–7.
Bahat G, et al. Comorbidities, polypharmacy, functionality and nutritional status in Turkish community-dwelling female elderly. Aging Clin Exp Res. 2014;26(3):255–9.
PubMed Article Google Scholar
Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170(18):1648–54.
PubMed Article Google Scholar
Garfinkel D. Poly-de-prescribing to treat polypharmacy: efficacy and safety. Ther Adv Drug Saf. 2018;9(1):25–43.
PubMed Article Google Scholar
Potter K, et al. Deprescribing in frail older people: a randomised controlled trial. PLoS One. 2016;11(3):e0149984.
PubMed PubMed Central Article CAS Google Scholar
Page AT, et al. Deprescribing in older people. Maturitas. 2016;91:115–34.
PubMed Article Google Scholar
Gnjidic D, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237–53.
PubMed Article Google Scholar
Lynch T. Management of drug–drug interactions: considerations for special populations: focus on opioid use in the elderly and long term care. Am J Manag Care. 2011;17(Suppl. 11):S293–8.
PubMed Google Scholar
Wolfstadt JI, et al. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008;23(4):451–8.
PubMed PubMed Central Article Google Scholar
Ancker JS, et al. Effects of workload, work complexity, and repeated alerts on alert fatigue in a clinical decision support system. BMC Med Inform Decis Mak. 2017;17(1):36.
PubMed PubMed Central Article Google Scholar
Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6(6):212–33.
CAS PubMed PubMed Central Article Google Scholar
Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging. 2010;27(12):947–57.
PubMed Article Google Scholar
Beers MH, et al. Explicit criteria for determining inappropriate medication use in nursing home residents: UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825–32.
CAS PubMed Article Google Scholar
American Geriatrics Society. 2015 updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–46.
Article Google Scholar
Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113–21.
CAS PubMed Article Google Scholar
Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–9.
PubMed Article Google Scholar
Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–54.
CAS PubMed Article Google Scholar
Hamilton H, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11):1013–9.
PubMed Article Google Scholar
O’Mahony D, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.
Article PubMed Google Scholar
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Ärztebl Int. 2010;107(31–32):543–51.
PubMed PubMed Central Google Scholar
Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–31.
PubMed Article Google Scholar
Rognstad S, et al. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: a modified Delphi study. Scand J Prim Health Care. 2009;27(3):153–9.
PubMed PubMed Central Article Google Scholar
Naugler CT, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000;7(2):103–7.
CAS PubMed Google Scholar
McLeod P, et al. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ. 1997;156:385–91.
CAS PubMed PubMed Central Google Scholar
Rancourt C, et al. Potentially inappropriate prescriptions for older patients in long-term care. BMC Geriatr. 2004;4:9.
PubMed PubMed Central Article Google Scholar
Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging. 2008;25(9):777–93.
PubMed Article Google Scholar
Basger BJ, Chen TF, Moles RJ. Validation of prescribing appropriateness criteria for older Australians using the RAND/UCLA appropriateness method. BMJ Open. 2012;2(5):e001431.
PubMed PubMed Central Article Google Scholar
Winit-Watjana W, Sakulrat P, Kespichayawattana J. Criteria for high-risk medication use in Thai older patients. Arch Gerontol Geriatr. 2008;47(1):35–51.
PubMed Article Google Scholar
Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55(Suppl. 2):S373–82.
PubMed Article Google Scholar
Shekelle P, Maclean C, Morton S, Wenger N. ACOVE quality indicators. Ann Intern Med. 2001;135:653–67.
CAS PubMed Article Google Scholar
Hanlon JT, et al. Use of inappropriate prescription drugs by older people. J Am Geriatr Soc. 2002;50(1):26–34.
PubMed Article Google Scholar
Lapane KL, et al. Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes. J Am Geriatr Soc. 2011;59(7):1238–45.
PubMed PubMed Central Article Google Scholar
Salahudeen MS, Hilmer SN, Nishtala PS. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. J Am Geriatr Soc. 2015;63(1):85–90.
PubMed Article Google Scholar
Tosato M, et al. Potentially inappropriate drug use among hospitalised older adults: results from the CRIME study. Age Ageing. 2014;43(6):767–73.
PubMed Article Google Scholar
Wehling M. Multimorbidity and polypharmacy: how to reduce the harmful drug load and yet add needed drugs in the elderly? Proposal of a new drug classification: fit for the aged. J Am Geriatr Soc. 2009;57(3):560–1.
PubMed Article Google Scholar
Wehling M, et al. VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. Age Ageing. 2016;45(2):262–7.
PubMed Article Google Scholar
Kuhn-Thiel AM, Weiss C, Wehling M. Consensus validation of the FORTA (Fit fOR The Aged) list: a clinical tool for increasing the appropriateness of pharmacotherapy in the elderly. Drugs Aging. 2014;31(2):131–40.
CAS PubMed Article Google Scholar
BPAC. A practical guide to stopping medicines in older people. Best Pract J. 2010;27;10–23.
Google Scholar
Scott IA, et al. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med. 2012;125(6):529–37.e4.
PubMed Article Google Scholar
Farrell B, et al. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process. PLoS One. 2015;10(4):e0122246.
PubMed PubMed Central Article CAS Google Scholar
Onder G, et al. Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing. 2013;42(3):284–91.
PubMed Article Google Scholar
Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29(6):453–62.
PubMed Article Google Scholar
Ellis G, et al. Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials. BMJ. 2011;343:d6553.
PubMed PubMed Central Article Google Scholar
Schmader KE, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med. 2004;116(6):394–401.
PubMed Article Google Scholar
Hanlon JT, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.
CAS Article PubMed Google Scholar
Schmader KE, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother. 1997;31(5):529–33.
CAS PubMed Article Google Scholar
Drenth-van Maanen AC, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners. Drugs Aging. 2009;26(8):687–701.
PubMed Article Google Scholar
Vogt-Ferrier N. Reviewing a complicated geriatric drug regimen. Eur Geriatr Med. 2010;1(3):198–202.
Article Google Scholar
Olsson IN, Curman B, Engfeldt P. Patient focused drug surveillance of elderly patients in nursing homes. Pharmacoepidemiol Drug Saf. 2010;19(2):150–7.
PubMed Article Google Scholar
Onder G, et al. Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project. Drugs Aging. 2014;31(1):33–45.
PubMed Article Google Scholar
Moorhouse P, Mallery LH. Palliative and therapeutic harmonization: a model for appropriate decision-making in frail older adults. J Am Geriatr Soc. 2012;60(12):2326–32.
PubMed Article Google Scholar
Dalhousie University. Faculty of Medicine continuing medical education. 8 Jan 2014. Available from: http://cme.medicine.dal.ca/ADS.htm. Accessed 2 May 2018.
Mallery LH, et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program. J Am Med Dir Assoc. 2013;14(11):801–8.
PubMed Article Google Scholar
Mallery LH, et al. Promoting higher blood pressure targets for frail older adults: a consensus guideline from Canada. Cleve Clin J Med. 2014;81(7):427–37.
PubMed Article Google Scholar
Scott IA, et al. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med. 2013;18(4):121–4.
PubMed Article Google Scholar
Pollock M, Bazaldua OV, Dobbie AE. Appropriate prescribing of medications: an eight-step approach. Am Fam Physician. 2007;75(2):231–6.
PubMed Google Scholar
Scott IA, Gray LC, Martin JH, et al. Effects of a drug minimisation guide on prescribing intentions in elderly persons with polypharmacy. Drugs Aging. 2012;29:659–67.
PubMed Google Scholar
Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Israel Med Assoc J. 2007;9(6):430–4.
Google Scholar
Sackett DL, et al. Evidence based medicine: what it is and what it isn’t. BMJ. 1996;312(7023):71–2.
CAS PubMed PubMed Central Article Google Scholar
Canadian Institute for Health Information. Seniors and the health care system: what Is the impact of multiple chronic conditions? 2011. Available from: https://secure.cihi.ca/free_products/air-chronic_disease_aib_en.pdf. Accessed 2 May 2018.
Reeve E, et al. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508–14.
PubMed Article Google Scholar
Tannenbaum C, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–8.
PubMed Article CAS Google Scholar
Starfield B. Threads and yarns: weaving the tapestry of comorbidity. Ann Fam Med. 2006;4(2):101–3.
PubMed PubMed Central Article Google Scholar
Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004;116(3):179–85.
PubMed Article Google Scholar
May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. 2009;339:b2803.
PubMed Article Google Scholar
Mangin D, Heath I. Multimorbidity and quaternary prevention (P4). Revista Brasileira de Medicina de Família e Comunidade. 2015;10(35):5.
Article Google Scholar
Starfield B, Mangin D. An international perspective on the basis for payment for performance. Qual Prim Care. 2010;18:399–404.
PubMed Google Scholar
Chutka DS, Takahashi PY, Hoel RQW. Inappropriate medications for elderly patients. Mayo Clin Proc. 2004;79(1):122–39.
CAS PubMed Article Google Scholar
Morton A. Inappropriately defining “inappropriate medication for the elderly”. J Am Geriatr Soc. 2004;52(9):1580.
PubMed Article Google Scholar
Steinman MA, et al. Agreement between drugs-to-avoid criteria and expert assessments of problematic prescribing. Arch Intern Med. 2009;169(14):132632.
Article Google Scholar
de Souto Barreto P, Ferrandez AM, Saliba-Serre B. Are older adults who volunteer to participate in an exercise study fitter and healthier than nonvolunteers? The participation bias of the study population. J Phys Act Health. 2013;10(3):359–67.
Article Google Scholar
Golomb BA, et al. The older the better: are elderly study participants more non-representative? A cross-sectional analysis of clinical trial and observational study samples. BMJ Open. 2012;2(6):e000833.
PubMed PubMed Central Article Google Scholar
Kaiser C, et al. Selection bias of elderly patients with chronic angina referred for catheterization. Int J Cardiol. 2006;110(1):80–5.
CAS PubMed Article Google Scholar
Sugisawa H, Kishino H, Sugihara Y, Okabayashi H, Shibata H. Comparison of characteristics between respondents and nonrespondents in a national survey of Japanese elderly using six year follow-up study. Nihon Koshu Eisei Zasshi. 1999;46(7):551–62 (in Japanese).
CAS PubMed Google Scholar
Sugisawa H, Kishino H, Sugihara Y, Shibata H. Characteristics of dropouts and participants in a twelve-year longitudinal research of Japanese elderly. Nihon Koshu Eisei Zasshi. 2000;47(4):337–49 (in Japanese).
CAS PubMed Google Scholar
Boyd CM, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.
CAS PubMed Article Google Scholar
Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.
CAS PubMed Article Google Scholar
Starfield B, Gérvas J, Mangin D. Clinical care and health disparities. Annu Rev Public Health. 2012;33:89–106.
CAS PubMed Article Google Scholar
Angell M. The truth about drug companies: how they deceive us and what to do about it. Random House; 2005.
Golomb BA. Conflict of Interest in Medicine. 5 Oct 2008. Available from: http://thesciencenetwork.org/programs/beyond-belief-candles-in-the-dark/beatrice-golomb. Accessed 2 May 2018.
Gotzsche P. Deadly medicines and organised crime. London: Radcliffe Medical Press; 2013.
Google Scholar
Healy D. Let them eat Prozac: the unhealthy relationship between the pharmaceutical industry and depression. New York: New York University Press; 2006.
Google Scholar
Healy D. Pharmageddon. California: University of California Press; 2012.
Book Google Scholar
Healy D, Cattel D. Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatry. 2003;183(1):22–7.
PubMed Article Google Scholar
Doshi P, et al. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ. 2013;346:f2865.
PubMed PubMed Central Article Google Scholar
Chan A, et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. J Am Med Assoc. 2004;291(20):2457–65.
CAS Article Google Scholar
Bero L, et al. Factors associated with findings of published trials of drug–drug comparisons: why some statins appear more efficacious than others. PLoS Med. 2007;4(6):e184.
PubMed PubMed Central Article CAS Google Scholar
Ciani O, et al. Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study. BMJ. 2013;346:f457.
PubMed PubMed Central Article Google Scholar
Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. J Am Med Assoc. 2002;287(5):612–7.
Article Google Scholar
Gordon J. The under-representation of elderly patients in a problem-based medical school curriculum. Med Teach. 2007;29(8):844.
PubMed Article Google Scholar
Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096–9.
CAS PubMed PubMed Central Article Google Scholar
Gill SS, et al. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med. 2005;165(7):808–13.
PubMed Article Google Scholar
Anderson K, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.
PubMed PubMed Central Article Google Scholar
Reeve E, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.
PubMed Article Google Scholar
Checkland K, et al. Biomedicine, holism and general medical practice: responses to the 2004 General Practitioner contract. Sociol Health Illn. 2008;30(5):788–803.
PubMed Article Google Scholar
Marengoni A, et al. Prevalence of chronic diseases and multimorbidity among the elderly population in Sweden. Am J Public Health. 2008;98(7):1198–200.
PubMed PubMed Central Article Google Scholar
Barnett K, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.
PubMed Article Google Scholar
Mangin D, Sweeney K, Heath I. Preventive health care in elderly people needs rethinking. BMJ. 2007;335(7614):285–7.
PubMed PubMed Central Article Google Scholar
Multimorbidity: clinical assessment and management, National Institute For Health and Care Excellence guideline [NG56]. 2016: United Kingdom nice.org.uk/guidance/ng56.

Page 2

From: International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action

1.	Drug-specific adverse effects
2.	Drug–drug interaction
3.	Drug–disease interaction
4.	Cognitive impairment/delirium [5,6,7,8]
5.	Weight loss, malnutrition [9, 10]
6.	Falls [11,12,13,14,15]
7.	Hip fractures [12]
8.	Urinary incontinence [16]
9.	Functional impairment, immobility [17, 18]
10.	Hospitalization [17, 19,20,21,22,23,24,25,26]
11.	Nursing home, long-term care placement [20,21,22,23,24, 27]
12.	Decrease in quality of life [27]
13.	Death [27]
14.	Reduced treatment adherence [28]
15.	Increased cost to the health system and to the individual [17, 20,21,22,23,24, 29,30,31,32,33,34,35,36]